Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Sponsorship Statement: This continuing education activity is sponsored by 
Support Statement: The content contained in this activity was developed from the live activity that was supported by an educational grant from Allergan, Inc.
Title: The Role of Intraocular Corticosteroids in the Management of Retinal Disorders
Learning Objectives:
At the conclusion of this activity participants should be able to:
- Describe the conditions in which intraocular steroids would be the preferred treatment option for a patient with diabetic macular edema
- Identify patients with retinal vein occlusion who are candidates for treatment with intraocular steroids
- Evaluate the potential use of intraocular steroids as combination therapy in the treatment of AMD
- Discuss preventative steps to limit the risk of side effects in patients undergoing retinal procedures
Target Audience: The target audience for this activity is retinal specialists, and other healthcare professionals involved in the treatment of eyecare patients.
Course Chair:
Carmen A. Puliafito, MD, MBA
Retina/Vitreous Section Editor
OCULAR SURGERY NEWS
Dean, Keck School of Medicine
Professor of Ophthalmology
and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, California
Faculty:
Delivery Steroids to the Retina: Review of Available Technologies
Baruch D. Kuppermann, MD, PhD
Professor of Ophthalmology and Biomedical Engineering
Chief, Retina Service
Vice-Chair, Clinical Research
The Gavin Herbert Eye Institute
University of California
Irvine, California
The Wills Experience in Sustained Delivery of Steroids
Allen C. Ho, MD
Editorial Board Member
OCULAR SURGERY NEWS
Professor of Ophthalmology
Wills Eye Institute
Mid Atlantic Retina
Philadelphia, Pennsylvania
A New Treatment Algorithim for Combining Anti-VEGF Agents and Sustained Delivery Steroids for Managing Retinal Vascular Occlusion
Michael A. Singer, MD
Retina Macular Degeneration and Diabetic Eye Specialist
Medical Center Ophthalmology Associates
San Antonio, TX
Continuing Medical Education Information:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of OCULAR SURGERY NEWS® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, November 17, 2010 to November 16, 2011.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the Pretest questions, read the articles, complete the CME Posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the Posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty members report the following relationship(s):
Carmen A. Puliafito, MD, MBA
Consultant: Zeiss Meditec
Baruch D. Kuppermann, MD, PhD
Consultant: Allergan, Genentech, Novagali, Alimera
Allen C. Ho, MD
Consultant: Alcon, Regeneron, QLT, Sanofi-Aventis, Oraya
Advisory Board: Alcon, Allergan, Eyetech, Genentech, Neovista, Ophthotech, Optherion, Regeneron, QLT Phototherapuetics
Research: Alcon, Allergan, Genentech, Lifeguard, NEI/NIH, Neovista, Macusight, Regeneron, QLT
Michael A. Singer, MD
Research Funds: Genentech, Regeneron, NeoVista, Macusight, Allergan, Alcon, Thrombogenics
Consulting: Allergan, ISTA, Alcon, Genentech
Reviewer reports the following relationship(s):
Bajet Nour (an employee of Vindico Medical Education)
Receipt of Intellectual Property Rights / Patent Holder: Virtual Nursing Clinic; Gross Anatomy Online
Consulting Fees: Oncology Challenge of America
Ownership Interest (Stocks): Bristol-Myers Squibb; Centocor; GlaxoSmithKline; Johnson & Johnson; Biomet
Vindico staff report the following relationship(s):
No relevant financial relationship to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Copyright© 2010 Slack Incorporated. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of OCULAR SURGERY NEWS® and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of OCULAR SURGERY NEWS® and Vindico Medical Education. Neither Ocular Surgery News®, Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.